Portal:ExRNA/FeaturedPathways
From WikiPathways
(Difference between revisions)
(Moved Parasramka et al to consortia section) |
(Added latest batch of ERCC pathways) |
||
| Line 45: | Line 45: | ||
|width=100px|{{#pwimage:Pathway:WP3596|250px||miR-517 relationship with ARCN1 and USP1}} | |width=100px|{{#pwimage:Pathway:WP3596|250px||miR-517 relationship with ARCN1 and USP1}} | ||
[http://www.ncbi.nlm.nih.gov/pubmed/26655797 Shields et al. A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression] | [http://www.ncbi.nlm.nih.gov/pubmed/26655797 Shields et al. A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression] | ||
| + | |- | ||
| + | |width=100px|{{#pwimage:Pathway:WP3967|250px||miR-509-3p alteration of YAP1/ECM axis}} | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/27036018 Pan et al. miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer] | ||
| + | |width=100px|{{#pwimage:Pathway:WP3968|250px||CTGF-mediated hyperthermia resistance}} | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/27806300 Hatakeyama et al. Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers] | ||
| + | |width=100px|{{#pwimage:Pathway:WP3969|250px||H19 action Rb-E2F1 signaling and CDK-β-catenin activity}} | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/27789274 Ohtsuka et al. H19 Noncoding RNA, an Independent Prognostic Factor, Regulates Essential Rb-E2F and CDK8-β-Catenin Signaling in Colorectal Cancer] | ||
| + | |width=100px|{{#pwimage:Pathway:WP2261|250px||Signaling Pathways in Glioblastoma}} | ||
|- | |- | ||
|width=100px|{{#pwimage:Pathway:WP2012|250px||miRs in Muscle Cell Differentiation}} | |width=100px|{{#pwimage:Pathway:WP2012|250px||miRs in Muscle Cell Differentiation}} | ||
| Line 77: | Line 85: | ||
|- | |- | ||
|width=100px|{{#pwImage:Pathway:WP2249|250px||Metastatic brain tumor}} | |width=100px|{{#pwImage:Pathway:WP2249|250px||Metastatic brain tumor}} | ||
| - | |width=100px|{{# | + | |width=100px|{{#pwImage:Pathway:WP1992|250px||TarBasePathway}} |
| + | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
|width=100px|{{#pwImage:Pathway:WP2001|250px||miR-targeted genes in adipocytes - TarBase}} | |width=100px|{{#pwImage:Pathway:WP2001|250px||miR-targeted genes in adipocytes - TarBase}} | ||
[http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
| Line 90: | Line 99: | ||
[http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
|width=100px|{{#pwImage:Pathway:WP2006|250px||miR-targeted genes in squamous cell - TarBase}} | |width=100px|{{#pwImage:Pathway:WP2006|250px||miR-targeted genes in squamous cell - TarBase}} | ||
| - | |||
| - | |||
| - | |||
[http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
|} | |} | ||
Revision as of 17:38, 7 March 2017
|
Image does not exist T-Cell Receptor and Co-stimulatory Signaling |
Image does not exist IL1 and megakaryotyces in obesity |
Image does not exist RNA interference Ozpolat et al. Liposomal siRNA nanocarriers for cancer therapy Thomas et al. Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways |
Image does not exist Extracellular vesicle-mediated signaling in recipient cells |
|
Image does not exist TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer |
Image does not exist mir34a and TGIF2 in osteoclastogenesis |
Image does not exist mir219 in Oligodendrocyte Differentiation and Myelination |
Image does not exist Apoptosis-related network due to altered Notch3 in ovarian cancer |
|
Image does not exist miR-222 in Exercise-Induced Cardiac Growth |
Image does not exist Hypoxia-mediated EMT and Stemness |
Image does not exist DDX1 as a regulatory component of the Drosha microprocessor |
Image does not exist EV release from cardiac cells and their functional effects Danielson and Das, Extracellular Vesicles in Heart Disease: Excitement for the Future? |
|
Image does not exist Rac1/Pak1/p38/MMP-2 pathway Gonzalez-Villasana et al. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer |
Image does not exist eIF5A regulation in response to inhibition of the nuclear export system Miyake et al. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A |
Image does not exist MFAP5-mediated ovarian cancer cell motility and invasiveness |
Image does not exist LncRNA-mediated mechanisms of therapeutic resistance Parasramka et al. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma |
|
Image does not exist ApoE and miR-146 in inflammation and atherosclerosis |
Image does not exist miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma |
Image does not exist mir-124 predicted interactions with cell cycle and differentiation |
Image does not exist miR-517 relationship with ARCN1 and USP1 |
|
Image does not exist miR-509-3p alteration of YAP1/ECM axis |
Image does not exist CTGF-mediated hyperthermia resistance Hatakeyama et al. Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers |
Image does not exist H19 action Rb-E2F1 signaling and CDK-β-catenin activity |
Image does not exist Signaling Pathways in Glioblastoma |
|
Image does not exist miRs in Muscle Cell Differentiation |
Image does not exist REBF and miR33 in cholesterol and lipid homeostasis |
Image does not exist SRF and miRs in Smooth Muscle Differentiation and Proliferation |
Image does not exist Mecp2 and Associated Rett Syndrome |
|
Image does not exist Cell Differentiation |
Image does not exist Endoderm Differentiation |
Image does not exist Ectoderm Differentiation |
Image does not exist Mesodermal Commitment Pathway |
|
Image does not exist ErbB Signaling Pathway |
Image does not exist Mir302-367 Promoting Cardiomyocyte Proliferation |
Image does not exist Alzheimers Disease |
Image does not exist Parkinsons Disease |
|
Image does not exist MicroRNAs in cardiomyocyte hypertrophy |
Image does not exist Integrated Lung Cancer Pathway |
Image does not exist miRNA Biogenesis |
Image does not exist miRNA targets in ECM and membrane receptors |
|
Image does not exist Fluoropyrimidine Activity |
Image does not exist miRNAs involved in DNA damage response |
Image does not exist Metastatic Brain Tumor |
Image does not exist Regulatory RNA pathways |
|
Image does not exist Spinal Cord Injury |
Image does not exist miRNA Regulation of DNA Damage Response |
Image does not exist Parkinsons Disease Pathway (Mus musculus) |
Image does not exist Hepatitis C and Hepatocellular Carcinoma |
|
Image does not exist Metastatic brain tumor |
Image does not exist TarBasePathway |
Image does not exist miR-targeted genes in adipocytes - TarBase |
Image does not exist miR-targeted genes in epithelium - TarBase |
|
Image does not exist miR-targeted genes in lymphocytes - TarBase |
Image does not exist miR-targeted genes in muscle cell - TarBase |
Image does not exist miR-targeted genes in leukocytes - TarBase |
Image does not exist miR-targeted genes in squamous cell - TarBase |
